Free Trial

Edesa Biotech (EDSA) SEC Filings & 10K Form

Edesa Biotech logo
$2.14 -0.11 (-4.89%)
Closing price 08/1/2025 03:55 PM Eastern
Extended Trading
$2.25 +0.11 (+5.33%)
As of 08/1/2025 04:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Edesa Biotech SEC Filings

DateFilerForm TypeView
07/02/2025
8:01 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
8:44 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Marshall Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
8:24 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Sistilli Carlo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
8:29 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Olson Charles V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
8:18 PM
Brooks Michael J (Reporting)
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
8:19 PM
Chypyha Joan (Reporting)
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
8:19 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
MacDonald Sean Arthur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
8:21 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
8:00 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Weiler Peter J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
7:03 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Liu Da David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2025
3:05 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
3:46 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2025
4:28 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
3:20 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2025
3:22 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form DEF 14A
04/04/2025
3:23 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form DEFA14A
04/04/2025
3:25 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form ARS
03/11/2025
11:15 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form EFFECT
03/11/2025
3:31 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 424B3
03/03/2025
7:00 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
4:16 PM
Edesa Biotech, Inc. (Subject)
Edesa Biotech (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SCHEDULE 13G
02/14/2025
4:15 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form D
Notice of Exempt Offering of Securities 
02/14/2025
4:16 PM
Edesa Biotech, Inc. (Subject)
Edesa Biotech (Subject)
Nijhawan Pardeep (Filed by)
Form SCHEDULE 13D/A
02/14/2025
4:01 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Marshall Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
4:01 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
4:02 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Sistilli Carlo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
6:16 AM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
7:00 AM
Edesa Biotech, Inc. (Subject)
Edesa Biotech (Subject)
SATTERFIELD THOMAS A JR (Filed by)
Form SCHEDULE 13G/A
02/04/2025
6:32 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:01 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:40 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 10-K/A
12/13/2024
3:45 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/13/2024
3:40 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
8:08 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
8:29 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
7:49 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
7:50 PM
Edesa Biotech, Inc. (Subject)
Edesa Biotech (Subject)
Nijhawan Pardeep (Filed by)
Form SC 13D/A
10/31/2024
7:30 AM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
3:55 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
4:05 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 424B5
10/02/2024
8:30 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad)

The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.

See his full breakdown of the seven stocks to own now
09/03/2024
7:00 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
3:45 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
3:30 PM
Edesa Biotech, Inc. (Filer)
Edesa Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2024
8:01 PM
Edesa Biotech, Inc. (Issuer)
Edesa Biotech (Issuer)
Nijhawan Pardeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:EDSA) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners